New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Take the survey

›ETF Issuers›RISE ETF›253280

253280

RISE Healthcare ETF

Passive ETF Equity

Not rated

The 253280 Exchange Traded Fund (ETF) is provided by RISE ETF. It is built to track an index: FnGuide Inc Healthcare Index. The 253280 ETF provides physical exposure, so by buying it you actually own parts of all the 45 underlying holdings. This share class generates a stream of income by distributing dividends.

₩11,905

+₩505 (+4.43%) 2 days ago

12:00 AM 07/31/26 Closed

1D price range

₩11,500₩11,915

52W price range

₩11,489.83₩19,747.81

YTD Perf.

-31.66%

YTD Flows

Annualized volatility

Fund AuM

€3.9M

Share class AuM

€3.9M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

KR7253280002

TER

0.4%

Inception date

9/23/2016

Issuer

RISE ETF

Benchmark

FnGuide Inc Healthcare Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
143860 Mirae Asset TIGER HEALTH CARE ETF	-2.95%
266420 Samsung KODEX Healthcare ETF	-2.96%

API

PerformanceDec 30, 2025 - Jul 30, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 06/30/26

Healthcare

90.46%

Industrials

7.80%

Non-Energy Materials

1.65%

Unavailable

0.10%

Latest 253280 news

No content available for this fund

FAQ about 253280

253280 is a Passive ETF. This ETF provides exposure to South Korean Health Care Equities.

253280 tracks the FnGuide Inc Healthcare Index - KRW, through a full replication replication method.

253280 carries a total expense ratio (TER) of 0.4%, indicating the annual cost for holding the fund.

253280 was introduced to the market on September 23, 2016. It trades on Moldova, Republic of, among other exchanges

RISE Healthcare ETF, 253280, is provided by RISE ETF. Learn more about RISE ETF here.

253280 oversees €3.9M in assets as of July 30, 2026.

253280 follows a distributing dividend policy, meaning it pays out income to investors. As of July 30, 2026, its 12-month trailing yield was 0.22%.

As of June 30, 2026, 253280 has significant geographic allocations in Republic of Korea.

As of June 30, 2026, 253280 focuses largely on Healthcare, Industrials and Non-Energy Materials.

As of June 30, 2026, 253280 holds 45 positions in its portfolio, with 79.23% of assets concentrated in its top 15 holdings.

As of June 30, 2026, 253280 top three holdings include SAMSUNG BIOLOGICS Co., Ltd., Celltrion, Inc. and Alteogen, Inc..

The base currency of 253280 is KRW.

Top 10 holdings

Data as of 06/30/26

SAMSUNG BIOLOGICS Co., Ltd.

10.53%

Celltrion, Inc.

10.24%

Alteogen, Inc.

10.19%

HLB Co., Ltd.

7.80%

ABL Bio, Inc.

5.33%

LigaChem Biosciences, Inc.

5.02%

Yuhan Corp.

4.91%

SK Biopharmaceuticals Co., Ltd.

4.39%

SAM CHUN DANG PHARM Co., Ltd.

3.98%

Samsung Epis Holdings Co., Ltd.

3.57%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The ETF Industry Is Evolving Fast

RISE Healthcare ETF

FAQ about 253280

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US